Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jim Pace"'
Publikováno v:
Bioorg Med Chem Lett
Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (pj) can lead to serious health consequences in patients with an immunocompromised system. Trimethoprim (TMP), used as first-line therapy in combination with sulfamethoxazole, is a selecti
Publikováno v:
Bioorganic & Medicinal Chemistry. 26:2640-2650
To combine the potency of trimetrexate (TMQ) or piritrexim (PTX) with the species selectivity of trimethoprim (TMP), target based design was carried out with the X-ray crystal structure of human dihydrofolate reductase (hDHFR) and the homology model
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:2669-2677
A major concern of immunocompromised patients, in particular those with AIDS, is susceptibility to infection caused by opportunistic pathogens such as Pneumocystis jirovecii , which is a leading cause of pneumonia in immunocompromised patients. We re
Publikováno v:
Journal of Structural Biology. 176:52-59
In order to produce a more potent replacement for trimethoprim (TMP) used as a therapy for Pneumocystis pneumonia and targets dihydrofolate reductase from Pneumocystis jirovecii (pjDHFR), it is necessary to understand the determinants of potency and
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 67:875-880
In order to understand the structure–activity profile observed for a series of substituted dibenz[b,f]azepine antifolates, the crystal structure of the binary complex of human dihydrofolate reductase (hDHFR) with the potent and selective inhibito
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 66:1271-1277
The crystal structures of six human dihydrofolate reductase (hDHFR) ternary complexes with NADPH and a series of mixed E/Z isomers of 5-substituted 5-[2-(2-methoxyphenyl)-prop-1-en-1-yl]furo[2,3-d]pyrimidine-2,4-diamines substituted at the C9 positio
Autor:
Sherry F. Queener, Vivian Cody, Jim Pace, Dixy W. Green, Linda A. Warnke, Michael A. Ihnat, Yibin Zeng, Lu Lin, Wei Li, Aleem Gangjee
Publikováno v:
Bioorganic & Medicinal Chemistry. 17:7324-7336
To optimize dual receptor tyrosine kinase (RTK) and dihydrofolate reductase (DHFR) inhibition, the E- and Z-isomers of 5-[2-(2-methoxyphenyl)prop-1-en-1-yl]furo[2,3-d]pyrimidine-2,4-diamines (1a and 1b) were separated by HPLC and the X-ray crystal st
Publikováno v:
Acta Crystallographica Section F Structural Biology and Crystallization Communications. 65:762-766
The crystal structure of the ternary complex of human dihydrofolate reductase (hDHFR) with NADPH and the Z isomer of 2,4-diamino-5-[2-(2'-methoxyphenyl)propenyl]-furo[2,3-d]pyrimidine (Z1) shows that the Z isomer binds in the normal antifolate orient
Publikováno v:
Journal of Medicinal Chemistry. 52:4892-4902
N-{4-[(2-amino-6-ethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)thio]benzoyl}-L-glutamic acid 2 and thirteen nonclassical analogues 2a–2m were synthesized as potential dual thymidylate synthase (TS) and dihydrofolate reductase (DHFR) inhibitors
Publikováno v:
Acta Crystallographica Section D: Biological Crystallography
The structures of mouse DHFR holo enzyme and a ternary complex with NADPH and a potent inhibitor are described.
It has been shown that 2,4-diamino-6-arylmethylpteridines and 2,4-diamino-5-arylmethylpyrimidines containing an O-carboxylalkyloxy gr
It has been shown that 2,4-diamino-6-arylmethylpteridines and 2,4-diamino-5-arylmethylpyrimidines containing an O-carboxylalkyloxy gr